How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study
Authors:
- 14 August 2015
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (3) , 1131-1138
Abstract
Chemotherapy-induced nausea and vomiting (CINV) still remain frequent. The procedure for announcing the diagnosis (PAD) was an emblematic measure of the first French Plan Cancer aiming at providing patients with time to listen, information after cancer diagnosis, and discussion on treatments and their side effects. We aimed at assessing the risk factors of CINV, focusing on patients’ satisfaction with the PAD.Keywords
This publication has 22 references indexed in Scilit:
- Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomitingSupportive Care in Cancer, 2013
- The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of lifeSupportive Care in Cancer, 2012
- Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of lifeSupportive Care in Cancer, 2012
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conferenceAnnals of Oncology, 2010
- Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic ReviewJournal of Clinical Oncology, 2008
- The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 2006
- Patient expectation is a strong predictor of severe nausea after chemotherapyCancer, 2004
- Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patientsSupportive Care in Cancer, 2002
- Pre‐infusion expectations predict post‐treatment nausea during repeated adjuvant chemotherapy infusions for breast cancerBritish Journal of Health Psychology, 2000
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993